Chintda Santiskulvong, Ph.D.
Affiliations: | 2006 | University of California, Los Angeles, Los Angeles, CA |
Area:
Cell Biology, Molecular BiologyGoogle:
"Chintda Santiskulvong"Parents
Sign in to add mentor| Enrique Rozengurt | grad student | 2006 | UCLA | |
| (G -protein coupled receptor (GPCR)-induced epidermal growth factor receptor (EGFR) transactivation: Regulation and contribution to GPCR mitogenic signaling.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Qi D, Kaur Gill N, Santiskulvong C, et al. (2015) Screening cell mechanotype by parallel microfiltration. Scientific Reports. 5: 17595 |
| Wiedemeyer W, Qi D, Gill NK, et al. (2015) Abstract 226: Parallel microfiltration (PMF): A novel method to screen cell mechanotype Cancer Research. 75: 226-226 |
| Sharma S, Santiskulvong C, Rao J, et al. (2014) The role of Rho GTPase in cell stiffness and cisplatin resistance in ovarian cancer cells. Integrative Biology : Quantitative Biosciences From Nano to Macro. 6: 611-7 |
| Santiskulvong C, Sharma S, Bentolila L, et al. (2013) Abstract 2122: The role of Rho GTPase in cell stiffness and cisplatin resistance in ovarian cancer cells. Cancer Research. 73: 2122-2122 |
| Fekete M, Santiskulvong C, Eng C, et al. (2012) Effect of PI3K/Akt pathway inhibition-mediated G1 arrest on chemosensitization in ovarian cancer cells. Anticancer Research. 32: 445-52 |
| Sharma S, Santiskulvong C, Bentolila LA, et al. (2012) Correlative nanomechanical profiling with super-resolution F-actin imaging reveals novel insights into mechanisms of cisplatin resistance in ovarian cancer cells. Nanomedicine : Nanotechnology, Biology, and Medicine. 8: 757-66 |
| Santiskulvong C, Eng C, Wang DT, et al. (2012) Abstract 836: Insulin-like growth factor-I receptor (IGF-IR) dowregulation in cisplatin-resistant human ovarian cancer cells Cancer Research. 72: 836-836 |
| Santiskulvong C, Konecny GE, Fekete M, et al. (2011) Dual targeting of phosphoinositide 3-kinase and mammalian target of rapamycin using NVP-BEZ235 as a novel therapeutic approach in human ovarian carcinoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 17: 2373-84 |
| Karam AK, Santiskulvong C, Fekete M, et al. (2010) Cisplatin and PI3kinase inhibition decrease invasion and migration of human ovarian carcinoma cells and regulate matrix-metalloproteinase expression. Cytoskeleton (Hoboken, N.J.). 67: 535-44 |
| Santiskulvong C, Rozengurt E. (2007) Protein kinase Calpha mediates feedback inhibition of EGF receptor transactivation induced by Gq-coupled receptor agonists. Cellular Signalling. 19: 1348-57 |